Skip to main content
Log in

Biochanin A Inhibits Breast Cancer Tumor Growth in A Murine Xenograft Model

  •  
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

ABSTRACT

Purpose

Our objective was to determine the effect of the flavonoid biochanin A (BCA), administered alone or in combination with the flavonoids quercetin and epigallocatechin-3-gallate (EGCG), on the growth of human breast cancer MCF-7 cells in a murine xenograft animal model.

Materials and Methods

MCF-7 tumors were implanted into mice and groups of mice were treated with vehicle, BCA at 2 doses (5 or 15 mg/kg), quercetin and EGCG (5 mg/kg each), or BCA combined with quercetin and EGCG (5 mg/kg each). The flavonoids were injected once daily intraperitoneally, with treatment starting 4 weeks prior to cell inoculation.

Results

Treatment with 15 mg/kg of BCA or the mixture of the 3 flavonoids resulted in a reduction in tumor incidence. Tumor size in xenograft mice treated with 15 mg/kg BCA was significantly smaller than in the control group. Although quercetin/EGCG administration did not affect tumor size, treatment with the mixture of the 3 flavonoids at doses of 5 mg/kg produced similar effects as seen with 15 mg/kg BCA.

Conclusions

Our findings indicate that BCA inhibits tumor growth in a xenograft animal model; BCA may represent a breast cancer preventive agent, either administered alone or in combination with other flavonoids.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Abbreviations

BCA:

biochanin A

EGCG:

epigallocatechin-3-gallate

References

  1. www.cancer.org. Cancer Statistics 2007, American Cancer Society, Inc. Available at: http://www.cancer.org/. (2007).

  2. A. Brodie, Q. Lu, and J. Nakamura. Aromatase in the normal breast and breast cancer. J Steroid Biochem Mol Biol. 61:281–286 (1997).

    Article  PubMed  CAS  Google Scholar 

  3. C. A. Lamartiniere. Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr. 71:1705S–1707S; discussion 1708S–1709S (2000).

    PubMed  CAS  Google Scholar 

  4. S. Barnes, G. Peterson, C. Grubbs, and K. Setchell. Potential role of dietary isoflavones in the prevention of cancer. Adv Exp Med Biol. 354:135–147 (1994).

    PubMed  CAS  Google Scholar 

  5. C. E. Rufer, and S. E. Kulling. Antioxidant activity of isoflavones and their major metabolites using different in vitro assays. J Agric Food Chem. 54:2926–2931 (2006).

    Article  PubMed  CAS  Google Scholar 

  6. A. Kalayciyan, H. Orawa, S. Fimmel, F. H. Perschel, J. B. Gonzalez, R. G. Fitzner, C. E. Orfanos, and C. C. Zouboulis. Nicotine and biochanin A, but not cigarette smoke, induce anti-inflammatory effects on keratinocytes and endothelial cells in patients with Behcet's disease. J Invest Dermatol. 127:81–89 (2007).

    Article  PubMed  CAS  Google Scholar 

  7. S. Puli, J. C. Lai, and A. Bhushan. Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones. J Neurooncol. 79:135–142 (2006).

    Article  PubMed  CAS  Google Scholar 

  8. T. Gotoh, K. Yamada, H. Yin, A. Ito, T. Kataoka, and K. Dohi. Chemoprevention of N-nitroso-N-methylurea-induced rat mammary carcinogenesis by soy foods or biochanin A. Jpn J Cancer Res. 89:137–142 (1998).

    PubMed  CAS  Google Scholar 

  9. Y. S. Lee, J. S. Seo, H. T. Chung, and J. J. Jang. Inhibitory effects of biochanin A on mouse lung tumor induced by benzo(a)pyrene. J Korean Med Sci. 6:325–328 (1991).

    PubMed  CAS  Google Scholar 

  10. J. M. Cassady, T. M. Zennie, Y. H. Chae, M. A. Ferin, N. E. Portuondo, and W. M. Baird. Use of a mammalian cell culture benzo(a)pyrene metabolism assay for the detection of potential anticarcinogens from natural products: inhibition of metabolism by biochanin A, an isoflavone from Trifolium pratense L. Cancer Res. 48:6257–6261 (1988).

    PubMed  CAS  Google Scholar 

  11. Y. J. Moon, D. A. Brazeau, and M. E. Morris. Effects of flavonoids genistein and biochanin A on gene expression and their metabolism in human mammary cells. Nutr Cancer. 57:48–58 (2007).

    PubMed  CAS  Google Scholar 

  12. L. Rice, V. G. Samedi, T. A. Medrano, C. A. Sweeney, H. V. Baker, A. Stenstrom, J. Furman, and K. T. Shiverick. Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts. Prostate. 52:201–212 (2002).

    Article  PubMed  CAS  Google Scholar 

  13. K. Yanagihara, A. Ito, T. Toge, and M. Numoto. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res. 53:5815–5821 (1993).

    PubMed  CAS  Google Scholar 

  14. C. Ying, J. T. Hsu, and S. C. Shieh. Growth inhibition of human endothelial cells by the phyto-oestrogen biochanin A, a metabolite of genistein. Br J Nutr. 85:615–620 (2001).

    Article  PubMed  CAS  Google Scholar 

  15. J. T. Hsu, H. C. Hung, C. J. Chen, W. L. Hsu, and C. Ying. Effects of the dietary phytoestrogen biochanin A on cell growth in the mammary carcinoma cell line MCF-7. J Nutr Biochem. 10:510–517 (1999).

    Article  PubMed  CAS  Google Scholar 

  16. T. G. Peterson, L. Coward, M. Kirk, C. N. Falany, and S. Barnes. The role of metabolism in mammary epithelial cell growth inhibition by the isoflavones genistein and biochanin A. Carcinogenesis. 17:1861–1869 (1996).

    Article  PubMed  CAS  Google Scholar 

  17. J. R. Zhou, L. Yu, Z. Mai, and G. L. Blackburn. Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice. Int J Cancer. 108:8–14 (2004).

    Article  PubMed  CAS  Google Scholar 

  18. A. Murakami, D. Takahashi, K. Koshimizu, and H. Ohigashi. Synergistic suppression of superoxide and nitric oxide generation from inflammatory cells by combined food factors. Mutat Res. 523–524:151–161 (2003).

    PubMed  Google Scholar 

  19. M. Mouria, A. S. Gukovskaya, Y. Jung, P. Buechler, O. J. Hines, H. A. Reber, and S. J. Pandol. Food–derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int J Cancer. 98:761–769 (2002).

    Article  PubMed  CAS  Google Scholar 

  20. F. V. So, N. Guthrie, A. F. Chambers, M. Moussa, and K. K. Carroll. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer. 26:167–181 (1996).

    Article  PubMed  CAS  Google Scholar 

  21. K. B. Horwitz, M. E. Costlow, and W. L. McGuire. MCF-7; a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors. Steroids. 26:785–795 (1975).

    Article  PubMed  CAS  Google Scholar 

  22. C. Ying, J. T. Hsu, H. C. Hung, D. H. Lin, L. F. Chen, and L. K. Wang. Growth and cell cycle regulation by isoflavones in human breast carcinoma cells. Reprod Nutr Dev. 42:55–64 (2002).

    Article  PubMed  CAS  Google Scholar 

  23. S. T. Willard, and L. S. Frawley. Phytoestrogens have agonistic and combinatorial effects on estrogen-responsive gene expression in MCF-7 human breast cancer cells. Endocrine. 8:117–121 (1998).

    Article  PubMed  CAS  Google Scholar 

  24. H. Farhan, K. Wahala, H. Adlercreutz, and H. S. Cross. Isoflavonoids inhibit catabolism of vitamin D in prostate cancer cells. J Chromatogr B Analyt Technol Biomed Life Sci. 777:261–268 (2002).

    Article  PubMed  CAS  Google Scholar 

  25. M. S. Morton, P. S. Chan, C. Cheng, N. Blacklock, A. Matos-Ferreira, L. Abranches-Monteiro, R. Correia, S. Lloyd, and K. Griffiths. Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Prostate. 32:122–128 (1997).

    Article  PubMed  CAS  Google Scholar 

  26. Y. J. Moon and M. E. Morris. Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: Effects of quercetin and EGCG on biochanin A disposition in rats. Mol Pharm 4:865–872 (2007).

    Article  PubMed  CAS  Google Scholar 

  27. A. C. Pike, A. M. Brzozowski, R. E. Hubbard, T. Bonn, A. G. Thorsell, O. Engstrom, J. Ljunggren, J. A. Gustafsson, and M. Carlquist. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. Embo J. 18:4608–4618 (1999).

    Article  PubMed  CAS  Google Scholar 

  28. M. Lacey, J. Bohday, S. M. Fonseka, A. I. Ullah, and S. A. Whitehead. Dose-response effects of phytoestrogens on the activity and expression of 3beta-hydroxysteroid dehydrogenase and aromatase in human granulosa-luteal cells. J Steroid Biochem Mol Biol. 96:279–286 (2005).

    Article  PubMed  CAS  Google Scholar 

  29. N. R. Bianco, L. J. Chaplin, and M. M. Montano. Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage. Biochem J. 385:279–287 (2005).

    Article  PubMed  CAS  Google Scholar 

  30. X. Y. Sun, C. A. Plouzek, J. P. Henry, T. T. Wang, and J. M. Phang. Increased UDP-glucuronosyltransferase activity and decreased prostate specific antigen production by biochanin A in prostate cancer cells. Cancer Res. 58:2379–2384 (1998).

    PubMed  CAS  Google Scholar 

  31. Y. J. Moon, K. Sagawa, K. Frederick, S. Zhang, and M. E. Morris. Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats. AAPS J. 8:E433–442 (2006).

    Article  PubMed  CAS  Google Scholar 

  32. X. Jia, J. Chen, H. Lin, and M. Hu. Disposition of flavonoids via enteric recycling: enzyme-transporter coupling affects metabolism of biochanin A and formononetin and excretion of their phase II conjugates. J Pharmacol Exp Ther. 310:1103–1113 (2004).

    Article  PubMed  CAS  Google Scholar 

  33. M. H. Choi, K. R. Kim, J. K. Hong, S. J. Park, and B. C. Chung. Determination of non-steroidal estrogens in breast milk, plasma, urine and hair by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 16:2221–2228 (2002).

    Article  PubMed  CAS  Google Scholar 

  34. K. D. Setchell, N. M. Brown, P. Desai, L. Zimmer-Nechemias, B. E. Wolfe, W. T. Brashear, A. S. Kirschner, A. Cassidy, and J. E. Heubi. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr. 131:1362S–1375S (2001).

    PubMed  CAS  Google Scholar 

  35. J. Howes, M. Waring, L. Huang, and L. G. Howes. Long-term pharmacokinetics of an extract of isoflavones from red clover (Trifolium pratense). J Altern Complement Med. 8:135–142 (2002).

    Article  PubMed  Google Scholar 

  36. M. J. Messina, and C. L. Loprinzi. Soy for breast cancer survivors: a critical review of the literature. J Nutr. 131:3095S–3108S (2001).

    PubMed  CAS  Google Scholar 

  37. H. Mizunuma, K. Kanazawa, S. Ogura, S. Otsuka, and H. Nagai. Anticarcinogenic effects of isoflavones may be mediated by genistein in mouse mammary tumor virus-induced breast cancer. Oncology. 62:78–84 (2002).

    Article  PubMed  CAS  Google Scholar 

Download references

ACKNOWLEDGEMENT

This study was supported by grants from the Susan G. Komen and Cancer Research and Prevention Foundations. We thank Drs. Atif Awad and Carol Fink for their assistance with the murine xenograft model.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marilyn E. Morris.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moon, Y.J., Shin, B.S., An, G. et al. Biochanin A Inhibits Breast Cancer Tumor Growth in A Murine Xenograft Model. Pharm Res 25, 2158–2163 (2008). https://doi.org/10.1007/s11095-008-9583-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11095-008-9583-6

KEY WORDS

Navigation